Nana L. Roseno
Bispebjerg, Denmark
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Hidradenitis Suppurativa and Risk of Self-Harm and Suicide.
Journal: JAMA dermatology
Published: March 11, 2026
Patients With Chronic Urticaria Have Higher Health-Care Resource Utilisation: A Danish Nationwide Case-Control Study.
Journal: Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
Published: November 15, 2025
Genetic Susceptibility to Hidradenitis Suppurativa and Predisposition to Cardiometabolic Disease.
Journal: JAMA dermatology
Published: October 09, 2024
Biomarkers of systemic inflammation are associated with disease severity and metabolic syndrome in patients with hidradenitis suppurativa.
Journal: JAAD international
Published: March 03, 2024
The Copenhagen Hidradenitis Suppurativa Cohort: Insights from the First 8 Years.
Journal: Dermatology (Basel, Switzerland)
Published: February 10, 2024
Drug survival of biologics in hidradenitis suppurativa: A systematic review and meta-analysis.
Journal: Journal of the American Academy of Dermatology
Published: December 25, 2023
Long-term drug survival of adalimumab, infliximab, secukinumab and ustekinumab in hidradenitis suppurativa: a Danish nationwide cohort study.
Journal: The British journal of dermatology
Published: July 17, 2023
Adherence to therapy of ixekizumab and secukinumab in psoriatic arthritis patients using first- or second-line IL-17A inhibitor treatment: a Danish population-based cohort study.
Journal: Rheumatology (Oxford, England)
Published: April 25, 2023
Drug Survival of Adalimumab, Secukinumab, and Ustekinumab in Psoriasis as Determined by Either Dose Escalation or Drug Discontinuation during the First 3 Years of Treatment - a Nationwide Cohort Study.
Journal: The Journal of investigative dermatology
Published: October 05, 2022
Exploring disease comorbidities and temporal disease progression of psoriasis: an observational, retrospective, multi-database, cohort study.
Journal: The British journal of dermatology
Published: June 09, 2022
Drug survival of biologics and novel immunomodulators for rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, and psoriasis - A nationwide cohort study from the DANBIO and DERMBIO registries.
Journal: Seminars in arthritis and rheumatism
Published: December 09, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026